| 1 |
Wu Y, Liu X, Li X, et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in chinese adults [J].Circulation,2006,114(21):2217-2225.
|
| 2 |
EuropeanAssociationforCardiovascularPrevention&Rehabilitation, Reiner Z,Catapano AL,et al. ESC/EAS Guidelines for the management of dyslipidaemias: The task force for the management of dyslipidaemias of the European Society of Cardiology(ESC) and the European Atherosclerosis Society( EAS) [J]. Eur Heart J,2011,32(14):1769-1818.
|
| 3 |
Liu Y, Coresh J, Eustace JA, et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition [J]. JAMA,2004,291 (4):451-459.
|
| 4 |
D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study [J]. Circulation,2008,117(6):743-753.
|
| 5 |
Muntner P,He J,Astor BC,et al. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease:results from the atherosclerosis risk in communities study [J]. J Am Soc Nephrol,2005,16(2):529-538.
|
| 6 |
Libby P. The forgotten majority: unfinished business in cardiovascular risk reduction [J]. J Am Coll Cardiol, 2005, 46(7):1225-1228.
|
| 7 |
NKF-K/DOQI 慢性肾脏病血脂异常管理的临床实践指南[J].中国血液净化,2007,6(12):672-681.
|
| 8 |
Sharp Collaborative Group. Study of Heart and Renal Protection(SHARP): randomized trial to assess the effects of lowering lowdensity lipoprotein cholesterol among 9,438 patients with chronic kidney disease[J]. Am Heart J,2010,160(5):785-794.
|
| 9 |
Alcala A, Jansen S, Tellez T, et al. Statins improve visual field alterations related to hypercholesterolemia [ J]. Athrosclerosis,2010,269(2):512-514.
|
| 10 |
Fried LF, Orchard TJ, Kasiske BL. The effect of lipid reduction on renal disease progression: a meta-analysis. Kidney Int, 2001, 59(1):260-269.
|
| 11 |
Sabrina S, Natasha W, Linda FF, et al. Statins for improving renal outcomes: a meta-analysis [J]. J Am Soc Nephrol,2006,17(7):2006-2016.
|
| 12 |
Cholesterol Treatment Trialists' (CTT) Collaboration, Baigent C,Blackwell L, et al.Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials[J].Lancet,2010,376(9753):1670-1681.
|
| 13 |
Olsson B, Gigante B,Mehlig K, et al. Apolipoprotein C-1 genotype and serum levels of triglycerides, C-reactive protein and coronary heart disease [J]. Metabolism,2010,19(12):1736-1741.
|
| 14 |
National Kidney Foundation. KDOQITM Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease[J]. Am J Kidney Dis, 2007, 49(Suppl 2): S1-S180.
|
| 15 |
郭丹杰, 徐成斌. 贝特类调脂药物在降脂领域的地位及认识[J].临床药物治疗杂志,2008,6(2):1-3.
|
| 16 |
Aim-High Investigators. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy[J]. N Engl J Med, 2011,365(24):2255-2267.
|
| 17 |
Huxley RR, Barzi F, Lam TH, et al. Isolated low levels of highdensity lipoprotein cholesterol are associated with an increased risk of coronary heart disease: an individual participant data metaanalysis of 23 studies in the asia-pacific region [J]. Circulation,2011,124(19):2056-2064.
|
| 18 |
Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholester-ol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection):a randomised placebo-controlled trial[J]. Lancet, 2011, 377 (9784): 2181-2192.
|
| 19 |
Siscovick DS, Lemaitre RN, Mozaffarian D. The fish story: a dietheart hypothesis with clinical implications: N-3 polyunsaturated fatty acids,myocardial vulnerability,and sudden death [J]. Circulation,2003,107(21):2632-2634.
|
| 20 |
Ozsoy RC, Kastelein JJ, AriszL, et al. A torvas tat in and the dys lip -idem ia of early renal failure [J]. Atherosclerosis, 2003, 166(1) :187-194.
|
| 21 |
ACCORD Study Group.Effects of combination lipid therapy in type 2 diabetes mellitus[J].N Engl J Med,2010,362(17):1563-1574.
|
| 22 |
Baigent C,Landry M. Study of heart and renal protection (SHARP)[J]. Kidney Int,2003,63(Suppl 84): S207-S210.
|